Zoe M. Weinstein, MD, MS

Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Zoe M. Weinstein, MD, MS, is a graduate of Boston University’s Addiction Medicine Fellowship and board certified in Internal Medicine and Addiction Medicine. She has been the Director of Boston Medical Center’s interdisciplinary addiction consult service since July 2016. She has been NIDA grant funded as a co-investigator on multiple studies to deliver training and technical assistance to interdisciplinary provider teams (physicians, nurse practitioners, social workers, addiction counselors and recovery coaches) to expand treatment for opioid use disorder among hospitalized patients in New York City public hospitals as well as hospitals in Massachusetts as part of the HEALing Communities Study. She is currently site-PI of two NIDA Clinical Trial Network studies focused on inpatient addiction care. Her clinical and research work are also focused on long-term Office-Based Addiction Treatment (OBAT) with buprenorphine. She currently serves as Associate Director of Boston University’s Addiction Medicine Fellowship Program, a board member of AMERSA and is a site medical director of a local methadone clinic.

Publications

  • Published 3/4/2025

    Davoust M, Bazzi AR, Blakemore S, Blodgett J, Cheng A, Fielman S, Magane KM, Theisen J, Saitz R, Ventura AS, Weinstein ZM. Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study. Addict Sci Clin Pract. 2025 Mar 04; 20(1):21. PMID: 40033433.

    Read at: PubMed

  • Published 12/2/2024

    Bart G, Barth KS, Baukol P, Enns E, Ghitza UE, Harris J, Jelstrom E, Liebschutz JM, Magane KM, Voronca D, Weinstein ZM, Korthuis PT. Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder. Addict Sci Clin Pract. 2024 Dec 02; 19(1):91. PMID: 39623502.

    Read at: PubMed

  • Published 11/25/2024

    Shearer R, Englander H, Hagedorn H, Fawole A, Laes J, Titus H, Patten A, Oot E, Appleton N, Fitzpatrick A, Kibben R, Fernando J, McNeely J, Gustafson D, Krawczyk N, Weinstein Z, Baukol P, Ghitza U, Siegler T, Bart G, Bazzi A. Hospital Provider's Perspectives on MOUD Initiation and Continuation After Inpatient Discharge. J Gen Intern Med. 2024 Nov 25. PMID: 39586949.

    Read at: PubMed

  • Published 11/10/2024

    Weinstein ZM, Yu O, Wartko PD, Samet JH, Bobb JF, Braciszewski JM, Arnsten JH, Murphy MT, Horigian VE, Stotts AL, Beers D, Bradley K. Does implementation of office based addiction treatment by a nurse care manager increase the duration of OUD treatment in primary care? A secondary analysis of the PROUD randomized control trial. Drug Alcohol Depend. 2024 Dec 01; 265:112497. PMID: 39550823.

    Read at: PubMed

  • Published 11/8/2024

    Rosenmoss S, LaRochelle M, Bearnot B, Weinstein Z, So-Armah K, Moyo P, Yan S, Walley AY, Kimmel SD. Racial and Ethnic Disparities in Referral Rejection From Postacute Care Facilities Among People With Opioid Use Disorder in Massachusetts. J Addict Med. 2025 Mar-Apr 01; 19(2):165-171. PMID: 39514897.

    Read at: PubMed

View All 57 Publications:   View Full Profile in BUMC

Other Positions

  • Faculty, Medicine
    Boston University Chobanian & Avedisian School of Medicine

Websites

Education

  • University of California San Francisco, MD
  • Boston University School of Public Health, MS
  • Columbia University, BA

View all profiles